 | • レポートコード：MRC2-11QY11345 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は化学療法誘発性悪心・嘔吐（CINV）のグローバル市場について調査・分析したレポートです。種類別（CINV、PONV）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別化学療法誘発性悪心・嘔吐（CINV）の競争状況、市場シェア ・世界の化学療法誘発性悪心・嘔吐（CINV）市場：種類別市場規模 2015年-2020年（CINV、PONV） ・世界の化学療法誘発性悪心・嘔吐（CINV）市場：種類別市場規模予測 2021年-2026年（CINV、PONV） ・世界の化学療法誘発性悪心・嘔吐（CINV）市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界の化学療法誘発性悪心・嘔吐（CINV）市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米の化学療法誘発性悪心・嘔吐（CINV）市場分析：米国、カナダ ・ヨーロッパの化学療法誘発性悪心・嘔吐（CINV）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの化学療法誘発性悪心・嘔吐（CINV）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の化学療法誘発性悪心・嘔吐（CINV）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの化学療法誘発性悪心・嘔吐（CINV）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Eisai、ProStrakan、Helsinn Holding、Mundipharma、Qilu Pharma、Teva、Novartis、Heron Therapeutics、Roche、Mylan、Tesaro ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
Market Analysis and Insights: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Scope and Market Size
Chemotherapy-Induced Nausea and Vomiting (CINV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Eisai
ProStrakan
Helsinn Holding
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Market segment by Type, the product can be split into
CINV
PONV
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
1.4 Market by Type
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CINV
1.4.3 PONV
1.5 Market by Application
1.5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2015-2026)
2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Regions
2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Share by Regions (2015-2020)
2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Strategy
2.3.6 Primary Interviews with Key Chemotherapy-Induced Nausea and Vomiting (CINV) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Market Size
3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2015-2020)
3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2015-2020)
3.1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
3.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2019
3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
3.4 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
3.5 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2015-2020)
4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
6.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in North America (2019-2020)
6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
7.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Europe (2019-2020)
7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
8 China
8.1 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
8.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in China (2019-2020)
8.3 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
8.4 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
9.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Japan (2019-2020)
9.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
9.4 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
10.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
10.4 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
11 India
11.1 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in India (2019-2020)
11.3 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
11.4 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2015-2020)
12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020)
12.4 Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 ProStrakan
13.3.1 ProStrakan Company Details
13.3.2 ProStrakan Business Overview
13.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.3.5 ProStrakan Recent Development
13.4 Helsinn Holding
13.4.1 Helsinn Holding Company Details
13.4.2 Helsinn Holding Business Overview
13.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.4.5 Helsinn Holding Recent Development
13.5 Mundipharma
13.5.1 Mundipharma Company Details
13.5.2 Mundipharma Business Overview
13.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.5.5 Mundipharma Recent Development
13.6 Qilu Pharma
13.6.1 Qilu Pharma Company Details
13.6.2 Qilu Pharma Business Overview
13.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.6.5 Qilu Pharma Recent Development
13.7 Teva
13.7.1 Teva Company Details
13.7.2 Teva Business Overview
13.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.7.5 Teva Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Heron Therapeutics
13.9.1 Heron Therapeutics Company Details
13.9.2 Heron Therapeutics Business Overview
13.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.9.5 Heron Therapeutics Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
13.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
13.10.5 Roche Recent Development
13.11 Mylan
10.11.1 Mylan Company Details
10.11.2 Mylan Business Overview
10.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
10.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
10.11.5 Mylan Recent Development
13.12 Tesaro
10.12.1 Tesaro Company Details
10.12.2 Tesaro Business Overview
10.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
10.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020)
10.12.5 Tesaro Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Key Market Segments
Table 2. Key Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
Table 3. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CINV
Table 6. Key Players of PONV
Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2015-2020)
Table 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Growth Strategy
Table 17. Main Points Interviewed from Key Chemotherapy-Induced Nausea and Vomiting (CINV) Players
Table 18. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players (2015-2020)
Table 20. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2019)
Table 21. Global Chemotherapy-Induced Nausea and Vomiting (CINV) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
Table 24. Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Type (2015-2020)
Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2021-2026)
Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Application (2015-2020)
Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 34. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 36. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 38. Europe Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 40. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 42. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 44. China Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 46. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 47. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 48. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 49. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 50. Japan Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 52. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 54. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 58. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 60. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 62. India Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 64. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 65. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 66. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 67. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share (2019-2020)
Table 70. Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2015-2020)
Table 72. Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Eisai Company Details
Table 80. Eisai Business Overview
Table 81. Eisai Product
Table 82. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 83. Eisai Recent Development
Table 84. ProStrakan Company Details
Table 85. ProStrakan Business Overview
Table 86. ProStrakan Product
Table 87. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 88. ProStrakan Recent Development
Table 89. Helsinn Holding Company Details
Table 90. Helsinn Holding Business Overview
Table 91. Helsinn Holding Product
Table 92. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 93. Helsinn Holding Recent Development
Table 94. Mundipharma Company Details
Table 95. Mundipharma Business Overview
Table 96. Mundipharma Product
Table 97. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 98. Mundipharma Recent Development
Table 99. Qilu Pharma Company Details
Table 100. Qilu Pharma Business Overview
Table 101. Qilu Pharma Product
Table 102. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 103. Qilu Pharma Recent Development
Table 104. Teva Company Details
Table 105. Teva Business Overview
Table 106. Teva Product
Table 107. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 108. Teva Recent Development
Table 109. Novartis Business Overview
Table 110. Novartis Product
Table 111. Novartis Company Details
Table 112. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 113. Novartis Recent Development
Table 114. Heron Therapeutics Company Details
Table 115. Heron Therapeutics Business Overview
Table 116. Heron Therapeutics Product
Table 117. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 118. Heron Therapeutics Recent Development
Table 119. Roche Company Details
Table 120. Roche Business Overview
Table 121. Roche Product
Table 122. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 123. Roche Recent Development
Table 124. Mylan Company Details
Table 125. Mylan Business Overview
Table 126. Mylan Product
Table 127. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 128. Mylan Recent Development
Table 129. Tesaro Company Details
Table 130. Tesaro Business Overview
Table 131. Tesaro Product
Table 132. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2015-2020) (Million US$)
Table 133. Tesaro Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2020 VS 2026
Figure 2. CINV Features
Figure 3. PONV Features
Figure 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
Figure 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions: 2020 VS 2026
Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2019
Figure 14. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2019
Figure 16. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market The global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemoth…- 術後悪心嘔吐（PONV）の世界市場（～2026年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- CINV既存・パイプライン治療薬の世界市場（～2026年） Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV). Market Analysis and Insights: Global CINV Existing and Pipeline Drugs Market The global CINV Existing and Pipeline Drugs market size i…
- 化学療法好中球減少症治療の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy-Induced Neutropenia Treatment Market The global Chemotherapy-Induced Neutropenia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemotherapy-Induced Neutrope…